Stock Sale, Buyback News

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 31/10/2025 FR0013230612 1 03...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 184,961 shares of its common stock to 272 new non-executive employees and one non-qualified stock option award to purchase 5,731 shares of its common stock to one new non-executive employee with a grant date of Octobe...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable...

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of occupational health services, today announced results for its third quarter ended September 30, 2025, the declaration of a cash dividend, and raised guidance for full year 2025. “2025 has continued to be an excellent year for Concentra,” said Keith Newton, Chief Executive Officer of Concentra. “Building on our business growth in...

TAMPA, Fla.--(BUSINESS WIRE)--Exzeo Group, Inc. (NYSE:XZO) today announced the closing of its initial public offering (“IPO”) of 8,000,000 shares of its common stock at a public offering price of $21.00. All shares offered were sold by Exzeo. In addition, Exzeo has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 common shares at the IPO price, less underwriting discounts and commissions. The shares began trading on the New York Stock Exchange on November 5, 20...

NEW YORK--(BUSINESS WIRE)--Morgan Stanley Direct Lending Fund (NYSE: MSDL) (“MSDL” or the “Company”), a business development company externally managed by MS Capital Partners Adviser Inc. (the “Adviser”), today announced its financial results for the third quarter ended September 30, 2025. QUARTERLY HIGHLIGHTS Net investment income of $43.7 million, or $0.50 per share, as compared to $43.7 million, or $0.50 per share, for the quarter ended June 30, 2025; Net asset value of $20.41 per share, as...

CENTENNIAL, Colo.--(BUSINESS WIRE)--DHI Group, Inc. (NYSE: DHX) today announced that its Board of Directors authorized a new stock repurchase program that permits the repurchase of up to $5 million of the Company's common stock. This new authorization will be effective November 13, 2025 and is approved to run through November 12, 2026. Under the program, management has discretion in determining the conditions under which shares may be purchased from time to time, through open market purchases i...

FOSTER CITY, Calif.--(BUSINESS WIRE)--QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal first quarter ended September 30, 2025. For the fiscal first quarter, the Company reported revenue of $285.9 million, up 2% year-over-year. GAAP net income for the fiscal first quarter was $4.5 million, or $0.08 per diluted share. Adjusted net income for the fiscal fi...

ZURICH--(BUSINESS WIRE)--Regulatory News: UBS Group AG and UBS AG (NYSE:UBS) (SWX:UBSN), acting through its Stamford branch (each an “Offeror” and together the “Offerors”) announce today corrected pricing terms for each series of notes included in their previously announced seven concurrent and separate offers (each, an “Offer” and collectively, the “Offers”) to purchase outstanding notes of the series listed in the table below (collectively, the “Notes”). The Offers were made upon the terms an...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has approved a share repurchase program under which the Company is authorized to repurchase up to $10 million of outstanding common stock over approximately 24 months (the “Program”). “We believe Niagen Bioscience is an excellent investment and the Program is a compelling u...